China · Delayed Price · Currency is CNY PhiChem Statistics
Total Valuation
PhiChem has a market cap or net worth of CNY 29.67 billion. The enterprise value is 29.13 billion.
| Market Cap | 29.67B |
| Enterprise Value | 29.13B |
Important Dates
The next confirmed earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PhiChem has 566.95 million shares outstanding. The number of shares has increased by 4.83% in one year.
| Current Share Class | 566.95M |
| Shares Outstanding | 566.95M |
| Shares Change (YoY) | +4.83% |
| Shares Change (QoQ) | +3.17% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 8.74% |
| Float | 425.48M |
Valuation Ratios
The trailing PE ratio is 85.29 and the forward PE ratio is 49.38.
| PE Ratio | 85.29 |
| Forward PE | 49.38 |
| PS Ratio | 9.20 |
| PB Ratio | 5.88 |
| P/TBV Ratio | 7.85 |
| P/FCF Ratio | 169.30 |
| P/OCF Ratio | 44.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 49.70, with an EV/FCF ratio of 166.18.
| EV / Earnings | 74.61 |
| EV / Sales | 9.43 |
| EV / EBITDA | 49.70 |
| EV / EBIT | 73.88 |
| EV / FCF | 166.18 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.18 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.07 |
| Debt / FCF | 4.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.86% and return on invested capital (ROIC) is 9.36%.
| Return on Equity (ROE) | 8.86% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 9.36% |
| Return on Capital Employed (ROCE) | 9.22% |
| Weighted Average Cost of Capital (WACC) | 8.76% |
| Revenue Per Employee | 1.53M |
| Profits Per Employee | 185,550 |
| Employee Count | 2,104 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.05 |
Taxes
In the past 12 months, PhiChem has paid 62.74 million in taxes.
| Income Tax | 62.74M |
| Effective Tax Rate | 13.34% |
Stock Price Statistics
The stock price has increased by +163.55% in the last 52 weeks. The beta is 0.86, so PhiChem's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +163.55% |
| 50-Day Moving Average | 41.64 |
| 200-Day Moving Average | 29.13 |
| Relative Strength Index (RSI) | 55.05 |
| Average Volume (20 Days) | 89,273,638 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PhiChem had revenue of CNY 3.23 billion and earned 390.40 million in profits. Earnings per share was 0.71.
| Revenue | 3.23B |
| Gross Profit | 1.17B |
| Operating Income | 496.84M |
| Pretax Income | 470.19M |
| Net Income | 390.40M |
| EBITDA | 721.44M |
| EBIT | 496.84M |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 1.33 billion in cash and 779.32 million in debt, with a net cash position of 547.68 million or 0.97 per share.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 779.32M |
| Net Cash | 547.68M |
| Net Cash Per Share | 0.97 |
| Equity (Book Value) | 5.05B |
| Book Value Per Share | 8.88 |
| Working Capital | 1.91B |
Cash Flow
In the last 12 months, operating cash flow was 669.18 million and capital expenditures -493.90 million, giving a free cash flow of 175.28 million.
| Operating Cash Flow | 669.18M |
| Capital Expenditures | -493.90M |
| Depreciation & Amortization | 224.60M |
| Net Borrowing | -211.56M |
| Free Cash Flow | 175.28M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 36.41%, with operating and profit margins of 15.40% and 12.10%.
| Gross Margin | 36.41% |
| Operating Margin | 15.40% |
| Pretax Margin | 14.58% |
| Profit Margin | 12.10% |
| EBITDA Margin | 22.37% |
| EBIT Margin | 15.40% |
| FCF Margin | 5.43% |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 0.11 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.79% |
| Buyback Yield | -4.83% |
| Shareholder Yield | -4.64% |
| Earnings Yield | 1.32% |
| FCF Yield | 0.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for PhiChem is 31.73, which is -39.38% lower than the current price. The consensus rating is "Buy".
| Price Target | 31.73 |
| Price Target Difference | -39.38% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 13.22% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 15, 2019. It was a forward split with a ratio of 1.2.
| Last Split Date | May 15, 2019 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |